Atlas Trials

Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 Diabetes

Clinical trial NCT01720290 · COMPLETED

Trial details

NCT number
NCT01720290
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2002-07-25
Primary completion
2003-02-25
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.